Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 989 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

Stallergenes adopts Veeva CRM

Veeva CRM is said to enable improved customer targeting, increased understanding of customer behavior and enhanced coordination of data between the field force, medical affairs and marketing teams.

Sartorius introduces Sartobind pico with 0.08 ml

The small membrane volume of 0.08 ml reduces material consumption during testing and virus spiking studies to save cost during the initial development phases. Sartobind STIC PA anion-exchange

Prolor receives NOA for CTP-modified interferons

The company applies its patented Carboxyl Terminal Peptide (CTP) technology and its Reversible Pegylation technology to develop longer-acting, proprietary versions of already approved therapeutic proteins. The CTP technology

Shaanxi Aoxing to takeover Shaanxi Weinan

Under the acquisition, Shaanxi Weinan’s portfolio of 86 drugs and one health product will be added to the Shaanxi Aoxing’s current drug portfolio. Biostar Pharmaceutical Board chairman and

NJH secures $12.7m grant to develop AEOL 10150

The contract also supports the research on plasminogen activator (TPA) and Silabilin as MCM’s against sulfur mustard gas exposure. AEOL can also be used to treat pulmonary injuries